CRH is trading at $88.83, up 4.45% versus the September 25 close, with the immediate driver unclear.

  • No confirmed September 28 CRH announcement or other company-specific catalyst was found.
  • Arcosa shareholders approved the acquisition on September 4; that earlier milestone does not explain Monday’s sudden move by itself.
  • Broader futures were lower, so market direction does not explain CRH’s upward move. The UBS price-target reduction was reported before this session.